Cytomegalovirus (CMV) resistance to antivirals (Q34722194)

4 August 2017

1 reference

title

Cytomegalovirus (CMV) resistance to antivirals (English)

1 reference

4 August 2017

0 references

Drew WL

1

1 reference

4 August 2017

Paya CV

series ordinal

2

1 reference

4 August 2017

Emery V

series ordinal

3

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

American Journal of Transplantation

4 August 2017

published in

1 reference

4 August 2017

volume

1

1 reference

4 August 2017

issue

4

1 reference

4 August 2017

page(s)

307-312

1 reference

Ganciclovir resistance: a matter of time and titre

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.10403.X

Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.10403.X

Prevalence of Resistance in Patients Receiving Ganciclovir for Serious Cytomegalovirus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.10403.X

Prediction of cytomegalovirus load and resistance patterns after antiviral chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.10403.X

Mutation in region III of the DNA polymerase gene conferring foscarnet resistance in cytomegalovirus isolates from 3 subjects receiving prolonged antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.10403.X

Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant. The Ganciclovir Implant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.10403.X

Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.10403.X

Randomized, controlled study of the safety and efficacy of intravenous cidofovir for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.10403.X

Development of a point mutation assay for the detection of human cytomegalovirus UL97 mutations associated with ganciclovir resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.10403.X

Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.10403.X

inferred from DOI database lookup

7 January 2021

based on heuristic

A deletion mutation in region V of the cytomegalovirus DNA polymerase sequence confers multidrug resistance

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.10403.X

inferred from DOI database lookup

7 January 2021

based on heuristic

Cytomegalovirus (CMV) DNA load predicts relapsing CMV infection after solid organ transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.10403.X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1034/J.1600-6143.2001.10403.X

1 reference

4 August 2017

1 reference